Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RGNX
RGNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RGNX News
Regenxbio Faces Class Action Lawsuit Reminder
12h ago
Globenewswire
Notice of REGENXBIO Securities Class Action
19h ago
PRnewswire
Faruqi & Faruqi Investigates REGENXBIO Investor Losses
1d ago
PRnewswire
Notice of Class Action Lawsuit for REGENXBIO Securities
4d ago
Globenewswire
REGENXBIO Faces Securities Class Action Lawsuit
4d ago
PRnewswire
Denali Therapeutics Secures FDA Accelerated Approval for Avlayah
4d ago
Newsfilter
Notice of Class Action Lawsuit for REGENXBIO Securities
6d ago
PRnewswire
REGENXBIO Faces Class Action Lawsuit
6d ago
Globenewswire
Notice of Class Action Lawsuit for REGENXBIO Securities
Mar 23 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit for Misleading Statements
Mar 23 2026
Globenewswire
Faruqi & Faruqi Investigates REGENXBIO Investor Losses
Mar 22 2026
PRnewswire
REGENXBIO INC ANNOUNCES SETTLEMENT AGREEMENT WITH MUTUAL RELEASES OF PAST AND SOME FUTURE CLAIMS - SEC FILING
Mar 20 2026
moomoo
REGENXBIO INC ANNOUNCES SETTLEMENT AND RELEASE AGREEMENT WITH GLAXOSMITHKLINE DATED MARCH 18, 2026 - SEC FILING
Mar 20 2026
moomoo
Notice of Class Action Lawsuit for REGENXBIO Securities
Mar 20 2026
Globenewswire
Notice of Class Action Lawsuit for REGENXBIO Securities
Mar 20 2026
PRnewswire
Class Action Lawsuits Filed Against PayPal and REGENXBIO
Mar 19 2026
Globenewswire
Show More News
